1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

UCB Innere Medizin GmbH & Co. KG

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2016

Location

Germany

Primary Industry

Biotechnology

About

Founded in 2016 and based in Germany, UCB Innere Medizin GmbH & Co. KG (UCB Germany) engages in the marketing of medicine and therapies for cardiovascular and respiratory applications.
Current Investors
Paragon Partners

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Cardiology, Pharmaceuticals
Website
www.ucb.de
Company Stage
Mature
Total Amount Raised
Subscriber access only

Deals

Deals Type
IPO
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed UCB Innere Medizin GmbH & Co. KG 06 May 2021
Completed UCB Innere Medizin GmbH & Co. KG 30 Jul 2018
Displaying 1-2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.